The World of Health & Medicine News

US CDC ends emergency bird flu response as infections decline

US CDC ends emergency bird flu response as infections decline

The U.S. Centers for Disease Control and Prevention said on Monday it has ended its emergency response for H5N1 bird flu, owing to a decline in animal infections and no reports of human cases since February.

The emergency response was deactivated on July 2, the agency told Reuters, adding that surveillance and response for bird flu cases will continue under the purview of its influenza division.

The number of people monitored and tested for bird flu will be reported on a monthly basis, the agency said, adding that it will no longer report infection rates in animals on its website.

The virus has infected 70 people, mostly farm workers, and killed one person over the past year as it spread aggressively among cattle herds and poultry flocks.

Experts have warned that further spread of bird flu raises the risk of it becoming more transmissible to humans.

The current public health risk from H5N1 bird flu remains low, CDC said, adding that it will continue to monitor the situation and scale up activities as needed.

The country’s response to bird flu has faced several disruptions this year, including from staff exodus at the U.S. Department of Agriculture as part of the Trump administration’s wider efforts to shrink the federal workforce and the government cancelling a more than $700 million contract awarded to Moderna (MRNA.O), opens new tab for the late-stage development of its bird flu vaccine for humans.

Bloomberg News first reported that CDC has ended its emergency response, opens new tab for bird flu.

Emergency activation allows for additional support for a public health response, including staffing and other resources, to increase testing, surveillance and communications during an outbreak, according to CDC.

The CDC H5N1 bird flu response was activated on April 4, 2024.

spot_img

Explore more

spot_img

US NIH to cap publisher fees for federally funded research by...

US NIH to cap publisher fees for federally funded research by 2026  The U.S. National Institutes of Health said on Tuesday it plans to implement...

US FDA approves KalVista Pharma’s swelling disorder drug

US FDA approves KalVista Pharma's swelling disorder drug KalVista Pharmaceuticals (KALV.O), opens new tab said on Monday the U.S. Food and Drug Administration has approved its drug...

Mayo Clinic’s AI tool identifies 9 dementia types, including Alzheimer’s, with...

Mayo Clinic’s AI tool identifies 9 dementia types, including Alzheimer’s, with one scan   Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that...

Novo Nordisk submits higher Wegovy dose to the European Medicines Agency...

Novo Nordisk submits higher Wegovy dose to the European Medicines Agency for approval  Denmark's Novo Nordisk (NOVOb.CO), opens new tab said on Tuesday it had submitted a...

6 Things to Do Before 9 A.M. to Reduce Your Stroke...

6 Things to Do Before 9 A.M. to Reduce Your Stroke Risk, According to Experts A stroke can be a life-altering, and sometimes life-ending, event.1 And...

Demand for obesity drugs shoots up in India as Lilly, Novo...

Demand for obesity drugs shoots up in India as Lilly, Novo jostle for market share Demand for weight-loss drugs is rising at a fast clip...

Medical groups sue HHS, Kennedy over vaccine policy

Medical groups sue HHS, Kennedy over vaccine policy Several leading medical organizations on Monday filed a suit against the U.S. Department of Health and Human...

US measles cases hit 6-year high at 1277 cases, John Hopkins...

US measles cases hit 6-year high at 1277 cases, John Hopkins data shows Measles cases in the United States have already reached a six-year high...